<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.genomebiology.com/feeds/articlecomments?arxId=gb-2006-7-10-r101&amp;format=rss&amp;version=&amp;quantity=">
        <title>Article Comments - 'A consensus prognostic gene expression classifier for ER positive breast cancer'</title>
        <link>http://genomebiology.com/2006/7/10/R101/comments</link>
        <description>The latest comments on the article 'A consensus prognostic gene expression classifier for ER positive breast cancer'</description>
        <dc:date>2006-11-17T10:42:28Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://genomebiology.com/2006/7/10/R101" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://genomebiology.com/2006/7/10/R101/comments#246526">
        <title>Why Sotiriou2006 did not use Wang et al dataset</title>
        <link>http://genomebiology.com/2006/7/10/R101/comments#246526</link>
        <description>&lt;p&gt;The authors wrote in the discussion:&lt;/p&gt;&lt;p&gt;&quot;Intriguingly though, the grade-derived signature was not validated in a large available cohort [11], raising doubts as to its wider applicability.&quot;&lt;/p&gt;&lt;p&gt;The grade signature was not applied to Wang et al. cohort in the Sotirou 2006 paper because histologic grade data were not publicly available , and therefore the cohort can not be used to answer our main question. That is, figure 2 of Sotiriou et al. can not be produced without histologic grade information.&lt;/p&gt;&lt;p&gt;The grade-index can be applied to this cohort, with hazard ratio 2.53 (1.62-3.94), under the cutoff that gives the same ratio of &quot;poor&quot; and &quot;good&quot; prognostic groups as that in figure 3b of this commented paper (Teschendorff et al.), in order to make the hazard ratios comparable. The HR above is similar to the one reported in figure 3b (2.38 [1.38-3.69]). Note that we use all 209 ER+ patients, while figure 3b of Teschendorff et al. only used 144 patients.&lt;/p&gt;</description>
                <dc:creator>Pratyaksha Wirapati</dc:creator>
                <dc:date>2006-11-17T10:42:28Z</dc:date>
        <prism:references>http://genomebiology.com/2006/7/10/R101</prism:references>
        <prism:person>Teschendorff et al.</prism:person>
        <prism:publicationName>Genome Biology</prism:publicationName>
        <prism:volume>7</prism:volume>
        <prism:startingPage>R101</prism:startingPage>
        <prism:publicationDate>Tue Oct 31 00:00:00 GMT 2006</prism:publicationDate>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

